Bromocriptine has 10 known drug interactions based on U.S. FDA drug labeling data. Of these, 2 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Metoclopramide, Metoclopramide Hydrochloride, Cyclosporine. Patients taking Bromocriptine should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 10
- Contraindicated
- 2
- Moderate
- 8
Contraindicated (2)
- Bromocriptine + Metoclopramide— Dopaminergic agonist with opposing effects on dopamine. Avoid concomitant use to prevent exacerbation of parkinsonian sy…
- Bromocriptine + Metoclopramide Hydrochloride— Dopaminergic agonist with opposing effects on dopamine; potential exacerbation of symptoms. Avoid concomitant use.
Moderate (8)
- Bromocriptine + Cyclosporine— Increases cyclosporine concentrations. Dosage adjustment essential.
- Bromocriptine + Lanreotide Acetate— Concomitant administration may increase the absorption of bromocriptine.
- Bromocriptine + Octreotide— Dose adjustment of bromocriptine may be necessary when used concomitantly with octreotide.
- Bromocriptine + Octreotide Acetate— Concomitant administration of octreotide and bromocriptine increases the availability of bromocriptine.
- Bromocriptine + Pasireotide— Co-administration may increase blood levels of bromocriptine; dose reduction of bromocriptine may be necessary.
- Bromocriptine + Rapamycin— Weak/moderate CYP3A4/P-gp inhibitor that may increase sirolimus concentrations. Monitor and adjust dosage as needed.
- Bromocriptine + Tamoxifen Citrate— Concomitant bromocriptine therapy elevates serum tamoxifen and N-desmethyl tamoxifen concentrations.
- Bromocriptine + Tizanidine Hydrochloride— Not recommended for concomitant use; hypotensive effects may be cumulative.